Gene · 2053
Papers2,484
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,484
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs. | Life (Basel) | 2025 | 40868936 | PubTator, text mining | PubMed |
| Integrative Mendelian randomization and multi-omics analysis identifies anti-allergic drug targets associated with cardiovascular disease risk. | Sci Rep | 2025 | 40841572 | PubTator, text mining | PubMed |
| Target discovery-directed pharmacological mechanism elucidation of bioactive natural products. | Med Rev (2021) | 2025 | 40838108 | PubTator, text mining | PubMed |
| Exploring the Role of Peroxisome-Related Processes and Key Marker Genes in Sepsis: Insights Into Immune Dynamics and Therapeutic Potential. | J Inflamm Res | 2025 | 40831516 | PubTator, text mining | PubMed |
| EETs Reduction Contributes to Granulosa Cell Senescence and Endometriosis-Associated Infertility via the PI3K/AKT/mTOR Signaling Pathway. | Adv Sci (Weinh) | 2025 | 40827571 | PubTator, text mining | PubMed |
| The influence of soluble epoxide hydrolase inhibition and their PUFA-derived epoxides in osteoblast bone metabolism: an in vitro study. | Biochim Biophys Acta Mol Cell Biol Lipids | 2025 | 40752846 | PubTator, text mining | PubMed |
| Comprehensive analysis of cholesterol metabolism-related genes in prostate cancer: integrated analysis of single-cell and bulk RNA sequencing. | Discov Oncol | 2025 | 40736630 | PubTator, text mining | PubMed |
| Zinc, Soluble Epoxide Hydrolase, and the Pulmonary Vascular Paradox: Novel Insights into a Well-Known Phenomenon. | Am J Respir Crit Care Med | 2025 | 40720858 | PubTator, text mining | PubMed |
| Epoxide hydrolases are involved in the metabolism of 5(6)-epoxyeicosatrienoic acid. | Biochem Biophys Res Commun | 2025 | 40700807 | PubTator, text mining | PubMed |
| Molybdenum exposure causes kidney damage related to the excretion of heavy metals. | Ecotoxicol Environ Saf | 2025 | 40639232 | PubTator, text mining | PubMed |
| Reprogramming inflammation: Mechanisms and therapeutic targeting of eicosanoids and pro-resolving mediators. | Eur J Pharmacol | 2025 | 40623536 | PubTator, text mining | PubMed |
| Multi-omics Analysis Reveals Molecular Subtype of Mitochondrial Oxidative Stress and Prognostic Model Development in Sepsis. | Front Biosci (Landmark Ed) | 2025 | 40613299 | PubTator, text mining | PubMed |
| Endothelial soluble epoxide hydrolase links polyunsaturated fatty acid metabolism to oxidative stress and atherosclerosis progression. | Redox Biol | 2025 | 40554101 | PubTator, text mining | PubMed |
| The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer's disease. | J Inflamm (Lond) | 2025 | 40551105 | PubTator, text mining | PubMed |
| EPHX2 overexpression deters the advancement of clear cell renal cell carcinoma via lipid metabolism reprogramming. | Front Oncol | 2025 | 40538850 | PubTator, text mining | PubMed |
| Structure-Based Design of PROTACS for the Degradation of Soluble Epoxide Hydrolase. | J Med Chem | 2025 | 40532036 | PubTator, text mining | PubMed |
| Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore. | Bioorg Chem | 2025 | 40466300 | PubTator, text mining | PubMed |
| Eicosanoid metabolites in relation to non-small cell lung cancer. | Biomed Pharmacother | 2025 | 40460550 | PubTator, text mining | PubMed |
| Twin Study Provides Heritability Estimates for 2321 Plasma Proteins and Assesses Missing SNP Heritability. | J Proteome Res | 2025 | 40425507 | PubTator, text mining | PubMed |
| Changes in Protein Expression of Renal Drug Transporters and Drug-Metabolizing Enzymes in Autosomal Dominant Polycystic Kidney Disease Patients. | Clin Pharmacol Ther | 2025 | 40371605 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2053/papers?page=6